Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Koch

Showing results (601-610 of 726) with videos related to

Pageof 73
Sort By:
Expert Opinion on Drug Safety|May 19, 2020
Psychotropic drug concentrations and clinical outcomes in children and adolescents: a systematic reviewSanne M Kloosterboer, Denise Vierhout, Jana Stojanova, et al.
British Journal of Clinical Pharmacology|September 30, 2017
Population pharmacodynamic modelling of midazolam induced sedation in terminally ill adult patientsLinda G Franken, Brenda C M de Winter, Anniek D Masman, et al.
Dermatology (Basel, Switzerland)|September 1, 2016
Combination Therapy of Etanercept and Fumarates versus Etanercept Monotherapy in Psoriasis: A Randomized Exploratory StudyJi Sun van Bezooijen, Deepak M W Balak, Martijn B A van Doorn, et al.
JCO Oncology Practice|June 7, 2024
Effect of Switching the Histamine-1 Receptor Antagonist Clemastine to Cetirizine in Paclitaxel Premedication Regimens: The H1-Switch StudyRuben Malmberg, Leni van Doorn, Juul M Cox, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 16, 2016
Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidolL G Franken, B C M de Winter, H J van Esch, et al.
Cancers|July 2, 2021
Population Pharmacokinetics of Oxycodone and Metabolites in Patients with Cancer-Related PainBram C Agema, Astrid W Oosten, Sebastiaan D T Sassen, et al.
Angewandte Chemie (International Ed. in English)|June 5, 2014
Deorphaning pyrrolopyrazines as potent multi-target antimalarial agentsDaniel Reker, Michael Seet, Max Pillong, et al.
Journal of Hypertension|December 3, 2021
Introducing the importance and difficulties of a three-step approach to improve nonadherence to antihypertensive drugs: a case seriesLaura E J Peeters, Jeroen B van der Net, Kathy Schoenmakers-Buis, et al.
Oncogene|May 15, 2023
A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage responseJonas P Koch, Selina M Roth, Aurélie Quintin, et al.
Breast (Edinburgh, Scotland)|September 17, 2025
Capacity and cost benefits of subcutaneous versus intravenous pertuzumab/trastuzumab: The EASE-SC studyMichiel Zietse, Jacky Hu, Esther R van Staveren, et al.
Pageof 73

Showing results (601-610 of 726) with videos related to

Sort By:
Pageof 73
Expert Opinion on Drug Safety|May 19, 2020
Psychotropic drug concentrations and clinical outcomes in children and adolescents: a systematic reviewSanne M Kloosterboer, Denise Vierhout, Jana Stojanova, et al.
British Journal of Clinical Pharmacology|September 30, 2017
Population pharmacodynamic modelling of midazolam induced sedation in terminally ill adult patientsLinda G Franken, Brenda C M de Winter, Anniek D Masman, et al.
Dermatology (Basel, Switzerland)|September 1, 2016
Combination Therapy of Etanercept and Fumarates versus Etanercept Monotherapy in Psoriasis: A Randomized Exploratory StudyJi Sun van Bezooijen, Deepak M W Balak, Martijn B A van Doorn, et al.
JCO Oncology Practice|June 7, 2024
Effect of Switching the Histamine-1 Receptor Antagonist Clemastine to Cetirizine in Paclitaxel Premedication Regimens: The H1-Switch StudyRuben Malmberg, Leni van Doorn, Juul M Cox, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 16, 2016
Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidolL G Franken, B C M de Winter, H J van Esch, et al.
Cancers|July 2, 2021
Population Pharmacokinetics of Oxycodone and Metabolites in Patients with Cancer-Related PainBram C Agema, Astrid W Oosten, Sebastiaan D T Sassen, et al.
Angewandte Chemie (International Ed. in English)|June 5, 2014
Deorphaning pyrrolopyrazines as potent multi-target antimalarial agentsDaniel Reker, Michael Seet, Max Pillong, et al.
Journal of Hypertension|December 3, 2021
Introducing the importance and difficulties of a three-step approach to improve nonadherence to antihypertensive drugs: a case seriesLaura E J Peeters, Jeroen B van der Net, Kathy Schoenmakers-Buis, et al.
Oncogene|May 15, 2023
A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage responseJonas P Koch, Selina M Roth, Aurélie Quintin, et al.
Breast (Edinburgh, Scotland)|September 17, 2025
Capacity and cost benefits of subcutaneous versus intravenous pertuzumab/trastuzumab: The EASE-SC studyMichiel Zietse, Jacky Hu, Esther R van Staveren, et al.
Pageof 73